Literature DB >> 10875853

Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens.

T Casals1, L Bassas, S Egozcue, M D Ramos, J Giménez, A Segura, F Garcia, M Carrera, S Larriba, J Sarquella, X Estivill.   

Abstract

Congenital absence of the vas deferens (CAVD) is a heterogeneous disorder, largely due to mutations in the cystic fibrosis (CFTR) gene. Patients with unilateral absence of the vas deferens (CUAVD) and patients with CAVD in association with renal agenesis appear to have a different aetiology to those with isolated CAVD. We have studied 134 Spanish CAVD patients [110 congenital bilateral absence of the vas deferens (CBAVD) and 24 CUAVD], 16 of whom (six CBAVD, 10 CUAVD) had additional renal anomalies. Forty-two different CFTR mutations were identified, seven of them being novel. Some 45% of the CFTR mutations were specific to CAVD, and were not found in patients with cystic fibrosis or in the general Spanish population. CFTR mutations were detected in 85% of CBAVD patients and in 38% of those with CUAVD. Among those patients with renal anomalies, 31% carried one CFTR mutation. Anomalies in seminal vesicles and ejaculatory ducts were common in patients with CAVD. The prevalence of cryptorchidism and inguinal hernia appeared to be increased in CAVD patients, as well as nasal pathology and frequent respiratory infections. This study confirms the molecular heterogeneity of CFTR mutations in CAVD, and emphasizes the importance of an extensive CFTR analysis in these patients. In contrast with previous studies, this report suggests that CFTR might have a role in urogenital anomalies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875853     DOI: 10.1093/humrep/15.7.1476

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

Review 1.  A missing vas.

Authors:  Z A Khan; J R Novell
Journal:  J R Soc Med       Date:  2001-11       Impact factor: 5.344

2.  Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.

Authors:  Els Dequeker; Manfred Stuhrmann; Michael A Morris; Teresa Casals; Carlo Castellani; Mireille Claustres; Harry Cuppens; Marie des Georges; Claude Ferec; Milan Macek; Pier-Franco Pignatti; Hans Scheffer; Marianne Schwartz; Michal Witt; Martin Schwarz; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

3.  A deficiency of lunatic fringe is associated with cystic dilation of the rete testis.

Authors:  K L Hahn; B Beres; Megan J Rowton; M K Skinner; Y Chang; A Rawls; J Wilson-Rawls
Journal:  Reproduction       Date:  2008-09-18       Impact factor: 3.906

4.  A rare frameshift variant in trans with the IVS9-5T allele of CFTR in a Chinese pedigree with congenital aplasia of vas deferens.

Authors:  Bin Ge; Mingzhe Zhang; Ruyi Wang; Dejing Wang; Tengyan Li; Hongjun Li; Binbin Wang
Journal:  J Assist Reprod Genet       Date:  2019-11-10       Impact factor: 3.412

5.  The prevalence of common CFTR mutations in Iranian infertile men with non-CAVD obstructive azoospermia by using ARMS PCR techniques.

Authors:  Kyumars Safinejad; Mojtaba Darbouy; Sayed Mahdi Kalantar; Sirus Zeinali; Reza Mirfakhraie; Leila Yadegar; Masoud Houshmand
Journal:  J Assist Reprod Genet       Date:  2011-10-06       Impact factor: 3.412

Review 6.  Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.

Authors:  D A S de Souza; F R Faucz; L Pereira-Ferrari; V S Sotomaior; S Raskin
Journal:  Andrology       Date:  2017-12-07       Impact factor: 3.842

7.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

Review 8.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

9.  Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered.

Authors:  Munir M Zaman; Andres Gelrud; Omer Junaidi; Meredith M Regan; Michel Warny; Julie C Shea; Ciaran Kelly; Brian P O'Sullivan; Steven D Freedman
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 10.  Is intracytoplasmic sperm injection safe? Current status and future concerns.

Authors:  D M Nudell; L I Lipshultz
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.